NsGene's Seed VC Round

NsGene raised a round of funding on , . Investors include Sunstone Capital.

NsGene, a biotech company based in Denmark and Providence, will develop its BrainRepair platform to treat cortico-basal degeneration, a rare neurological disorder with symptoms similar to Parkinson's …

Articles about NsGene's Seed VC Round: